1
Jean-luc Dubois
Samuel Devisme, Fabrice R Chop, Jean Laurent Pradel, Guillaume Le, Thomas Roussel, Jean Luc Dubois: Composition containing polypropylene and/or a propylene copolymer obtained from renewable materials, and uses thereof. Arkema France, December 15, 2011: US20110305900-A1

The present application relates to a method for manufacturing a propylene polymer, including: a) fermenting and optionally purifying first renewable materials to produce an alcohol or an alcohol mixture, the alcohol or alcohol mixture including at least isopropanol and/or at least a mixture of ethan ...


2

3
NAKANISHI Koji, YAMADA Kazunori: 情報表示装置、表示制御用集積回路、及び表示制御方法, Dispositif daffichage dinformations, circuit intégré pour le contrôle dun affichage et procédé de contrôle daffichage, Information display device, integrated circuit for display control, and display control method. Panasonic Corporation, NAKANISHI Koji, YAMADA Kazunori, OGASAWARA Shiro, December 15, 2011: WO/2011/155130 (34 worldwide citation)

Disclosed is an information display device which performs visible light communication and displays chronologically captured images on a screen while superimposing light source information transmitted from a light source on the images. The information display device is provided with an image capturin ...


4
TRABANCO SUÁREZ Andrés Avelino, TRESADERN Gary John, MACDONALD Gregor James, VEGA RAMIRO Juan Antonio: Dérivés de 5-amino-3,6-dihydro-1h-pyrazin-2-one utiles comme inhibiteurs de bêta-sécrétase (bace), 5-amino-3,6-dihydro-1h-pyrazin-2-one derivatives useful as inhibitors of beta-secretase (bace). Janssen Pharmaceutica, TRABANCO SUÁREZ Andrés Avelino, TRESADERN Gary John, MACDONALD Gregor James, VEGA RAMIRO Juan Antonio, December 15, 2011: WO/2011/154374 (33 worldwide citation)

The present invention relates to novel 5-amino-3,6-dihydro-1H-pyrazin-2-one derivatives as inhibitors of beta-secretase, also known as beta-site amyloid cleaving enzyme, BACE, BACE1, Asp2, or memapsin2. The invention is also directed to pharmaceutical compositions comprising such compounds, to proce ...


5
KANDULA Mahesh: Dérivés cystéamine et leur utilisation dans le traitement de stéatopathies non alcooliques (nash), Cysteamine derivatives and their use in the treatment of nash. KANDULA Mahesh, December 15, 2011: WO/2011/154833 (33 worldwide citation)

The disclosure herein provides a compound of formula I or its pharmaceutical acceptable salts, as well as polymorphs, solvates, and hydrates thereof. The steps of synthesis of compound of formula I is described. These salts may be formulated as pharmaceutical compositions. The pharmaceutical composi ...


6

7
LI Leping, ZHONG Min: Inhibiteurs de la protéine ns5a du vhc, Inhibitors of hcv ns5a protein. Presidio Pharmaceuticals, LI Leping, ZHONG Min, FARMER KOPPENOL Pauline, December 15, 2011: WO/2011/156543 (23 worldwide citation)

Provided herein are compounds, pharmaceutical compositions and combination therapies for treatment of hepatitis C.


8

9

10
KUDO Kazunori, NODA Masahiro: Appareil dintroduction dimplant oculaire et procédés associés, Ocular implant insertion apparatus and methods. Hoya Corporation, KUDO Kazunori, NODA Masahiro, USHIKI Mamoru, December 15, 2011: WO/2011/155636 (21 worldwide citation)

An exemplary ocular implant insertion system includes a case and a preloaded ocular implant insertion apparatus. The apparatus includes first and second movable structures that move the ocular implant in a predetermined sequence. The respective configurations of the case and the ocular implant inser ...



Click the thumbnails below to visualize the patent trend.